Class information for:
Level 1: MICAFUNGIN//CASPOFUNGIN//ECHINOCANDINS

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
5768 1578 36.7 77%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
7 4 INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY 1353914
156 3       MYCOSES//MYCOLOGY//CANDIDA ALBICANS 62026
55 2             CANDIDA ALBICANS//CANDIDA//ASPERGILLOSIS 29629
5768 1                   MICAFUNGIN//CASPOFUNGIN//ECHINOCANDINS 1578

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MICAFUNGIN authKW 2023129 11% 59% 178
2 CASPOFUNGIN authKW 1457713 11% 42% 180
3 ECHINOCANDINS authKW 1383683 11% 40% 180
4 ANIDULAFUNGIN authKW 1027032 6% 58% 91
5 FK463 authKW 174141 1% 100% 9
6 IMMUNOCOMPROMISED HOST SECT address 156844 3% 19% 43
7 PAPULACANDIN authKW 154792 1% 100% 8
8 PNEUMOCANDINS authKW 130601 1% 75% 9
9 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY journal 122512 24% 2% 386
10 GLUCAN SYNTHASE INHIBITOR authKW 116094 0% 100% 6

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Microbiology 23847 51% 0% 806
2 Pharmacology & Pharmacy 13487 54% 0% 847
3 Infectious Diseases 9392 23% 0% 368
4 Mycology 8163 9% 0% 147
5 Immunology 457 10% 0% 156
6 Chemistry, Medicinal 457 6% 0% 91
7 Biotechnology & Applied Microbiology 181 6% 0% 95
8 Dermatology 156 3% 0% 46
9 Chemistry, Organic 104 5% 0% 85
10 Veterinary Sciences 27 3% 0% 41

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 IMMUNOCOMPROMISED HOST SECT 156844 3% 19% 43
2 UNIDAD MICROBIOL EXPT 93412 1% 37% 13
3 IST MALATTIE INFETT MED PUBL 80619 0% 83% 5
4 GESTIONE P IDENZA MED CHIRURG 58047 0% 100% 3
5 INVEST BASICA NAT PROD DRUG DISCOVERY 58047 0% 100% 3
6 VICURON PHARMACEUT 58047 0% 100% 3
7 IST MALATTIE INFETT MED PUBBL 52230 1% 30% 9
8 KLIN STUDIENZENTRUM INFEKTIOL 2 51595 0% 67% 4
9 INFECT DIS PROGRAM 51039 1% 16% 16
10 MEDICAT USE ANAL CLIN 47617 1% 31% 8

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 122512 24% 2% 386
2 REVISTA IBEROAMERICANA DE MICOLOGIA 20546 1% 5% 20
3 MEDICAL MYCOLOGY 13904 2% 2% 39
4 JOURNAL OF ANTIBIOTICS 13373 4% 1% 68
5 MYCOSES 11921 3% 1% 43
6 JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 11643 6% 1% 87
7 INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 5461 2% 1% 33
8 JOURNAL DE MYCOLOGIE MEDICALE 4952 1% 2% 15
9 DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE 4661 2% 1% 36
10 REVISTA ESPANOLA DE QUIMIOTERAPIA 3135 1% 2% 8

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 MICAFUNGIN 2023129 11% 59% 178 Search MICAFUNGIN Search MICAFUNGIN
2 CASPOFUNGIN 1457713 11% 42% 180 Search CASPOFUNGIN Search CASPOFUNGIN
3 ECHINOCANDINS 1383683 11% 40% 180 Search ECHINOCANDINS Search ECHINOCANDINS
4 ANIDULAFUNGIN 1027032 6% 58% 91 Search ANIDULAFUNGIN Search ANIDULAFUNGIN
5 FK463 174141 1% 100% 9 Search FK463 Search FK463
6 PAPULACANDIN 154792 1% 100% 8 Search PAPULACANDIN Search PAPULACANDIN
7 PNEUMOCANDINS 130601 1% 75% 9 Search PNEUMOCANDINS Search PNEUMOCANDINS
8 GLUCAN SYNTHASE INHIBITOR 116094 0% 100% 6 Search GLUCAN+SYNTHASE+INHIBITOR Search GLUCAN+SYNTHASE+INHIBITOR
9 ENFUMAFUNGIN 99507 0% 86% 6 Search ENFUMAFUNGIN Search ENFUMAFUNGIN
10 ECHINOCANDIN B 94806 0% 70% 7 Search ECHINOCANDIN+B Search ECHINOCANDIN+B

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 CHEN, SCA , SLAVIN, MA , SORRELL, TC , (2011) ECHINOCANDIN ANTIFUNGAL DRUGS IN FUNGAL INFECTIONS A COMPARISON.DRUGS. VOL. 71. ISSUE 1. P. 11 -41 116 63% 124
2 POUND, MW , TOWNSEND, ML , DREW, RH , (2010) ECHINOCANDIN PHARMACODYNAMICS: REVIEW AND CLINICAL IMPLICATIONS.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 65. ISSUE 6. P. 1108 -1118 97 81% 23
3 EMRI, T , MAJOROS, L , TOTH, V , POCSI, I , (2013) ECHINOCANDINS: PRODUCTION AND APPLICATIONS.APPLIED MICROBIOLOGY AND BIOTECHNOLOGY. VOL. 97. ISSUE 8. P. 3267 -3284 101 65% 20
4 BASHA, A , BASHA, F , ALI, SK , HANSON, PR , MITSCHER, LA , OAKLEY, BR , (2013) RECENT PROGRESS IN THE CHEMOTHERAPY OF HUMAN FUNGAL DISEASES. EMPHASIS ON 1,3-BETA-GLUCAN SYNTHASE AND CHITIN SYNTHASE INHIBITORS.CURRENT MEDICINAL CHEMISTRY. VOL. 20. ISSUE 38. P. 4859-4887 125 58% 2
5 WAGNER, C , GRANINGER, W , PRESTERL, E , JOUKHADAR, C , (2006) THE ECHINOCANDINS: COMPARISON OF THEIR PHARMACOKINETICS, PHARMACODYNAMICS AND CLINICAL APPLICATIONS.PHARMACOLOGY. VOL. 78. ISSUE 4. P. 161-177 91 78% 64
6 SONG, JC , STEVENS, DA , (2016) CASPOFUNGIN: PHARMACODYNAMICS, PHARMACOKINETICS, CLINICAL USES AND TREATMENT OUTCOMES.CRITICAL REVIEWS IN MICROBIOLOGY. VOL. 42. ISSUE 5. P. 813 -846 98 58% 1
7 PEREA, JRA , (2016) ECHINOCANDINS: APPLIED PHARMACOLOGY.REVISTA IBEROAMERICANA DE MICOLOGIA. VOL. 33. ISSUE 3. P. 140 -144 71 85% 0
8 CAPPELLETTY, D , EISELSTEIN-MCKITRICK, K , (2007) THE ECHINOCANDINS.PHARMACOTHERAPY. VOL. 27. ISSUE 3. P. 369 -388 75 78% 120
9 MUILWIJK, EW , LEMPERS, VJC , BURGER, DM , WARRIS, A , PICKKERS, P , AARNOUTSE, RE , BRUGGEMANN, RJM , (2015) IMPACT OF SPECIAL PATIENT POPULATIONS ON THE PHARMACOKINETICS OF ECHINOCANDINS.EXPERT REVIEW OF ANTI-INFECTIVE THERAPY. VOL. 13. ISSUE 6. P. 799 -815 72 70% 3
10 ENOCH, DA , IDRIS, SF , ALIYU, SH , MICALLEF, C , SULE, O , KARAS, JA , (2014) MICAFUNGIN FOR THE TREATMENT OF INVASIVE ASPERGILLOSIS.JOURNAL OF INFECTION. VOL. 68. ISSUE 6. P. 507-526 73 70% 5

Classes with closest relation at Level 1


Rank Class id link
1 36486 SORDARIN//SORDARICIN//ZOFIMARIN
2 1659 CANDIDEMIA//CANDIDAEMIA//INVASIVE CANDIDIASIS
3 8574 VORICONAZOLE//POSACONAZOLE//HYDROXYITRACONAZOLE
4 9484 FLUCONAZOLE//MICRODILUTION TEST//SUSCEPTIBILITY TESTING
5 11732 CYP51A//AZOLE RESISTANCE//ISAVUCONAZOLE
6 781 INVASIVE ASPERGILLOSIS//ASPERGILLOSIS//INVASIVE FUNGAL INFECTION
7 16989 FLUCONAZOLE PROPHYLAXIS//CONGENITAL CANDIDIASIS//CANDIDA
8 24512 1 3 BETA GLUCAN SYNTHASE//PRODUCT ENTRAPMENT//SAPROLEGNIA MONOICA
9 3282 AMPHOTERICIN B//POLYENE ANTIBIOTICS//AMPHOTERICIN B LIPID COMPLEX
10 8371 CDR1//PDR5//PLEIOTROPIC DRUG RESISTANCE

Go to start page